Sun, Sep 21, 2014, 4:43 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Ariad Pharmaceuticals Inc. Message Board

  • plagioclase2002 plagioclase2002 Oct 26, 2010 5:18 AM Flag

    MY Thoughts

    Like most have been trying to think through recent events. After putting aside the good news - bad news - here are my thoughts. This will be the last dilution. Ariad will never be involved in the marketing of Ponatinib. The company will be sold as more of the value is proved. The timing - probably within 18 months. Ponatinib will weigh heavily in the price because part of the value of Ridaforolimus has already been sold via the advanced payments. My preliminary estimate $700 million - $1billion.

5.77+0.01(+0.17%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.